glp 1 pseudotumor cerebri Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension Use of glucagon-like peptide-1 receptor

These findings indicate potential pathways through which incretin therapy may: Stimulate bone formation by activating osteoblasts Inhibit bone resorption via osteoclast suppression Influence calcium and phosphate homeostasis Together, these mechanisms offer biologic plausibility that GLP1 RAs could help preserve bone strength

Researchers combed through health records from tens of thousands of adults with type 2 diabetes and found that those on GLP-1 drugs were more likely to be diagnosed with hair loss than those on two other diabetes medications

Sitagliptin improves vascular endothelial function in Japanese type 2 diabetes patients without cardiovascular disease

How Your Genetics Relate to GLP-1 Pathways Not everyone regains weight at the same rate after stopping GLP-1 therapygenetics play a significant role

A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk